Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
Lower tax rates overseas “drove a lot of the innovative companies to make drugs in low-tax islands like Ireland and Singapore and Switzerland,” said David Ricks, chief executive of Eli Lilly.
Simplified Text
Lower tax rates drove companies to make drugs in low-tax islands like Ireland Singapore and Switzerland according to David Ricks CEO of Eli Lilly.
Confidence Score
0.900
Claim Maker
David Ricks
Context Type
News Article
Context Details
{
    "topic": "Pharma Tariffs",
    "person": "David Ricks",
    "location": "Ireland, Singapore, Switzerland",
    "source_type": "News Article",
    "organization": "Eli Lilly"
}
Subject Tags
Business Economic Tax
UUID
9fdae13c-5464-48e0-9001-2f18d502448c
Vector Index
✗ No vector
Created
September 11, 2025 at 8:58 PM (3 days ago)
Last Updated
September 11, 2025 at 8:58 PM (3 days ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://www.nytimes.com/2025/08/14/health/pharma-tariffs-ireland-taxes.html
Tariffs Set to Hit Ireland, Where U.S. Drugmakers Play Tax Games
Pending
News
53 claims 🔥
3 days ago
https://www.nytimes.com/2025/08/14/health/pharma-tariffs-ireland-taxes.html

US drugmakers using Ireland for tax advantages face billions in tariffs on European medicines. Shifting production to the US increases costs. The situation highlights tax strategies and their impact.

Pharmaceutical Industry
International Trade
Taxation
Ireland
United States
Tariffs

Similar Claims (0)

Other claims identified as semantically similar to this one.

No similar claims found

This claim appears to be unique in the system.

Claim Management System - MVP